# Study of Bulevirtide in Participants With Chronic Hepatitis D Infection

> **NCT05718700** · — · ACTIVE_NOT_RECRUITING · sponsor: **Gilead Sciences** · enrollment: 170 (actual)

## Conditions studied

- Chronic Hepatitis D Infection

## Interventions

- **DRUG:** Bulevirtide

## Key facts

- **NCT ID:** NCT05718700
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-07
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05718700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05718700, "Study of Bulevirtide in Participants With Chronic Hepatitis D Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05718700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*